(Q42120343)

16 October 2017

A systems approach to analysis of molecular complexity in breast cancer (English)

1 reference

Ana Maria Gonzalez-Angulo

16 October 2017

series ordinal

2

object named as

Ana Maria Gonzalez-Angulo

1 reference

16 October 2017

4

Gordon B Mills

1 reference

16 October 2017

1

Bryan T Hennessy

1 reference

16 October 2017

Mark S Carey

3

1 reference

PMC publication ID

4161015

16 October 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

16 October 2017

Clinical Cancer Research

1 reference

16 October 2017

15

1 reference

16 October 2017

2

1 reference

16 October 2017

417-419

1 reference

Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161015

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

3 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19147744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19147744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-08-2620

1 reference

16 October 2017

1 reference

PMC publication ID

4161015

16 October 2017

PubMed publication ID

19147744

1 reference

PMC publication ID

4161015